SCHEMBL30007830

SCHEMBL30007830

CC(C)S(=O)(=O)c1ccc(-c2cnc3[nH]nc(C(=O)NCc4ccccc4)c3c2)cc1

nearest known ligand 0.45

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
DYRK1A Q13627 3/20 0.45
WNT1 P04628 2/20 0.45
GSK3A P49840 1/20 0.43
GSK3B P49841 1/20 0.43
KDR P35968 2/20 0.43
JAK2 O60674 1/20 0.43
MAP4K4 O95819 1/20 0.43
CHEK2 O96017 1/20 0.43
PRKCG P05129 1/20 0.43
CDK1 P06493 1/20 0.43
FES P07332 1/20 0.43
RET P07949 1/20 0.43
ROS1 P08922 1/20 0.43
FER P16591 1/20 0.43
FLT1 P17948 1/20 0.43
AXL P30530 1/20 0.43
FLT4 P35916 1/20 0.43
FLT3 P36888 1/20 0.43
MAPK9 P45984 1/20 0.43
IRAK1 P51617 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30007248 0.88 ATR (0.40) DYRK1AWNT1GSK3BNAMPTROCK2
SCHEMBL30007902 0.84 GSK3A (0.46) DYRK1AGSK3AGSK3BAXLATR
SCHEMBL30007677 0.83 AXL (0.50) KDRJAK2MAP4K4CHEK2PRKCG
SCHEMBL30007878 0.80 NAMPT (0.48) KDRJAK2MAP4K4CHEK2PRKCG
SCHEMBL30007738 0.75 KDM5A (0.42) GSK3AGSK3BROCK1LMNAROCK2
SCHEMBL29253947 0.73 GSK3A (0.48) DYRK1AGSK3AGSK3BJAK2PRKCG
SCHEMBL30912725 0.73 GSK3B (0.46) DYRK1AGSK3AGSK3BJAK2MAP4K4
SCHEMBL30912733 0.73 GSK3B (0.46) DYRK1AGSK3AGSK3BJAK2PRKCG
SCHEMBL29253946 0.73 GSK3B (0.46) DYRK1AGSK3AGSK3BJAK2MAP4K4
SCHEMBL29253944 0.73 GSK3B (0.46) DYRK1AGSK3AGSK3BJAK2PRKCG

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2022237922-A1 ANTITUMOR COMPOUNDS BASED ON NITROGEN HETEROCYCLES AND USE THEREOF AS MEDICAMENTS FAKULTNI NEMOCNICE HRADEC KRALOVE (CZ) 2022-11-17 WO claimed
WO-2022237922-A1 ANTITUMOR COMPOUNDS BASED ON NITROGEN HETEROCYCLES AND USE THEREOF AS MEDICAMENTS FAKULTNI NEMOCNICE HRADEC KRALOVE (CZ) 2022-11-17 WO disclosed